These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32369273)

  • 1. Consecutive medical exome analysis at a tertiary center: Diagnostic and health-economic outcomes.
    Kosaki R; Kubota M; Uehara T; Suzuki H; Takenouchi T; Kosaki K
    Am J Med Genet A; 2020 Jul; 182(7):1601-1607. PubMed ID: 32369273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proband-only medical exome sequencing as a cost-effective first-tier genetic diagnostic test for patients without prior molecular tests and clinical diagnosis in a developing country: the China experience.
    Hu X; Li N; Xu Y; Li G; Yu T; Yao RE; Fu L; Wang J; Yin L; Yin Y; Wang Y; Jin X; Wang X; Wang J; Shen Y
    Genet Med; 2018 Sep; 20(9):1045-1053. PubMed ID: 29095814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian cost-effectiveness analysis of Whole genome sequencing versus Whole exome sequencing in a pediatric population with suspected genetic disorders.
    Nurchis MC; Radio FC; Salmasi L; Heidar Alizadeh A; Raspolini GM; Altamura G; Tartaglia M; Dallapiccola B; Damiani G
    Eur J Health Econ; 2024 Aug; 25(6):999-1011. PubMed ID: 37975990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole exome sequencing in neurogenetic odysseys: An effective, cost- and time-saving diagnostic approach.
    Córdoba M; Rodriguez-Quiroga SA; Vega PA; Salinas V; Perez-Maturo J; Amartino H; Vásquez-Dusefante C; Medina N; González-Morón D; Kauffman MA
    PLoS One; 2018; 13(2):e0191228. PubMed ID: 29389947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single center experience with publicly funded clinical exome sequencing for neurodevelopmental disorders or multiple congenital anomalies.
    Pode-Shakked B; Barel O; Singer A; Regev M; Poran H; Eliyahu A; Finezilber Y; Segev M; Berkenstadt M; Yonath H; Reznik-Wolf H; Gazit Y; Chorin O; Heimer G; Gabis LV; Tzadok M; Nissenkorn A; Bar-Yosef O; Zohar-Dayan E; Ben-Zeev B; Mor N; Kol N; Nayshool O; Shimshoviz N; Bar-Joseph I; Marek-Yagel D; Javasky E; Einy R; Gal M; Grinshpun-Cohen J; Shohat M; Dominissini D; Raas-Rothschild A; Rechavi G; Pras E; Greenbaum L
    Sci Rep; 2021 Sep; 11(1):19099. PubMed ID: 34580403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disorders.
    Ewans LJ; Schofield D; Shrestha R; Zhu Y; Gayevskiy V; Ying K; Walsh C; Lee E; Kirk EP; Colley A; Ellaway C; Turner A; Mowat D; Worgan L; Freckmann ML; Lipke M; Sachdev R; Miller D; Field M; Dinger ME; Buckley MF; Cowley MJ; Roscioli T
    Genet Med; 2018 Dec; 20(12):1564-1574. PubMed ID: 29595814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the clinical utility of exome sequencing/Mono, Duo, Trio in prenatal testing: a retrospective study in a tertiary care centre in South India.
    Ilangovan H; Elangovan J; Danda S; Beck MM; Navaneethan P; Athiyarath R
    J Perinat Med; 2024 Jun; 52(5):520-529. PubMed ID: 38709224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exome first approach to reduce diagnostic costs and time - retrospective analysis of 111 individuals with rare neurodevelopmental disorders.
    Klau J; Abou Jamra R; Radtke M; Oppermann H; Lemke JR; Beblo S; Popp B
    Eur J Hum Genet; 2022 Jan; 30(1):117-125. PubMed ID: 34690354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A head-to-head evaluation of the diagnostic efficacy and costs of trio versus singleton exome sequencing analysis.
    Tan TY; Lunke S; Chong B; Phelan D; Fanjul-Fernandez M; Marum JE; Kumar VS; Stark Z; Yeung A; Brown NJ; Stutterd C; Delatycki MB; Sadedin S; Martyn M; Goranitis I; Thorne N; Gaff CL; White SM
    Eur J Hum Genet; 2019 Dec; 27(12):1791-1799. PubMed ID: 31320747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost trajectory of the diagnostic care pathway for children with suspected genetic disorders.
    Dragojlovic N; van Karnebeek CDM; Ghani A; Genereaux D; Kim E; Birch P; ; Elliott AM; Friedman JM; Lynd LD
    Genet Med; 2020 Feb; 22(2):292-300. PubMed ID: 31462755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating exome sequencing into a diagnostic pathway for epileptic encephalopathy: Evidence of clinical utility and cost effectiveness.
    Palmer EE; Schofield D; Shrestha R; Kandula T; Macintosh R; Lawson JA; Andrews I; Sampaio H; Johnson AM; Farrar MA; Cardamone M; Mowat D; Elakis G; Lo W; Zhu Y; Ying K; Morris P; Tao J; Dias KR; Buckley M; Dinger ME; Cowley MJ; Roscioli T; Kirk EP; Bye A; Sachdev RK
    Mol Genet Genomic Med; 2018 Mar; 6(2):186-199. PubMed ID: 29314763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of Ultra-Rapid Exome Sequencing in Critically Ill Infants and Children With Suspected Monogenic Conditions in the Australian Public Health Care System.
    ; Lunke S; Eggers S; Wilson M; Patel C; Barnett CP; Pinner J; Sandaradura SA; Buckley MF; Krzesinski EI; de Silva MG; Brett GR; Boggs K; Mowat D; Kirk EP; Adès LC; Akesson LS; Amor DJ; Ayres S; Baxendale A; Borrie S; Bray A; Brown NJ; Chan CY; Chong B; Cliffe C; Delatycki MB; Edwards M; Elakis G; Fahey MC; Fennell A; Fowles L; Gallacher L; Higgins M; Howell KB; Hunt L; Hunter MF; Jones KJ; King S; Kumble S; Lang S; Le Moing M; Ma A; Phelan D; Quinn MCJ; Richards A; Richmond CM; Riseley J; Rodgers J; Sachdev R; Sadedin S; Schlapbach LJ; Smith J; Springer A; Tan NB; Tan TY; Temple SL; Theda C; Vasudevan A; White SM; Yeung A; Zhu Y; Martyn M; Best S; Roscioli T; Christodoulou J; Stark Z
    JAMA; 2020 Jun; 323(24):2503-2511. PubMed ID: 32573669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of the traditional medical genetics diagnostic evaluation in the context of next-generation sequencing for undiagnosed genetic disorders.
    Shashi V; McConkie-Rosell A; Rosell B; Schoch K; Vellore K; McDonald M; Jiang YH; Xie P; Need A; Goldstein DB
    Genet Med; 2014 Feb; 16(2):176-82. PubMed ID: 23928913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-exome sequencing as the first-tier test for patients in neonatal intensive care unit: a Chinese single-center study.
    Zhang R; Cui X; Zhang Y; Ma H; Gao J; Zhang Y; Shu J; Cai C; Liu Y
    BMC Pediatr; 2024 May; 24(1):351. PubMed ID: 38778310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Exome Sequencing for Infants in Intensive Care Units: Ascertainment of Severe Single-Gene Disorders and Effect on Medical Management.
    Meng L; Pammi M; Saronwala A; Magoulas P; Ghazi AR; Vetrini F; Zhang J; He W; Dharmadhikari AV; Qu C; Ward P; Braxton A; Narayanan S; Ge X; Tokita MJ; Santiago-Sim T; Dai H; Chiang T; Smith H; Azamian MS; Robak L; Bostwick BL; Schaaf CP; Potocki L; Scaglia F; Bacino CA; Hanchard NA; Wangler MF; Scott D; Brown C; Hu J; Belmont JW; Burrage LC; Graham BH; Sutton VR; Craigen WJ; Plon SE; Lupski JR; Beaudet AL; Gibbs RA; Muzny DM; Miller MJ; Wang X; Leduc MS; Xiao R; Liu P; Shaw C; Walkiewicz M; Bi W; Xia F; Lee B; Eng CM; Yang Y; Lalani SR
    JAMA Pediatr; 2017 Dec; 171(12):e173438. PubMed ID: 28973083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved diagnostics by exome sequencing following raw data reevaluation by clinical geneticists involved in the medical care of the individuals tested.
    Basel-Salmon L; Orenstein N; Markus-Bustani K; Ruhrman-Shahar N; Kilim Y; Magal N; Hubshman MW; Bazak L
    Genet Med; 2019 Jun; 21(6):1443-1451. PubMed ID: 30377382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An efficient genetic test flow for multiple congenital anomalies and intellectual disability.
    Yokoi T; Enomoto Y; Tsurusaki Y; Harada N; Saito T; Nagai JI; Naruto T; Kurosawa K
    Pediatr Int; 2020 May; 62(5):556-561. PubMed ID: 31955471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions.
    Tan TY; Dillon OJ; Stark Z; Schofield D; Alam K; Shrestha R; Chong B; Phelan D; Brett GR; Creed E; Jarmolowicz A; Yap P; Walsh M; Downie L; Amor DJ; Savarirayan R; McGillivray G; Yeung A; Peters H; Robertson SJ; Robinson AJ; Macciocca I; Sadedin S; Bell K; Oshlack A; Georgeson P; Thorne N; Gaff C; White SM
    JAMA Pediatr; 2017 Sep; 171(9):855-862. PubMed ID: 28759686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test.
    Lionel AC; Costain G; Monfared N; Walker S; Reuter MS; Hosseini SM; Thiruvahindrapuram B; Merico D; Jobling R; Nalpathamkalam T; Pellecchia G; Sung WWL; Wang Z; Bikangaga P; Boelman C; Carter MT; Cordeiro D; Cytrynbaum C; Dell SD; Dhir P; Dowling JJ; Heon E; Hewson S; Hiraki L; Inbar-Feigenberg M; Klatt R; Kronick J; Laxer RM; Licht C; MacDonald H; Mercimek-Andrews S; Mendoza-Londono R; Piscione T; Schneider R; Schulze A; Silverman E; Siriwardena K; Snead OC; Sondheimer N; Sutherland J; Vincent A; Wasserman JD; Weksberg R; Shuman C; Carew C; Szego MJ; Hayeems RZ; Basran R; Stavropoulos DJ; Ray PN; Bowdin S; Meyn MS; Cohn RD; Scherer SW; Marshall CR
    Genet Med; 2018 Apr; 20(4):435-443. PubMed ID: 28771251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focused Exome Sequencing Gives a High Diagnostic Yield in the Indian Subcontinent.
    Duraisamy AJ; Liu R; Sureshkumar S; Rose R; Jagannathan L; da Silva C; Coovadia A; Ramachander V; Chandrasekar S; Raja I; Sajnani M; Selvaraj SM; Narang B; Darvishi K; Bhayal AC; Katikala L; Guo F; Chen-Deutsch X; Balciuniene J; Ma Z; Nallamilli BRR; Bean L; Collins C; Hegde M
    J Mol Diagn; 2024 Jun; 26(6):510-519. PubMed ID: 38582400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.